Biomass has received
significant attention in the 21st century
regarding its ability to become an alternative source of carbon for
the production of strategic chemicals and fuels. Although multiple
approaches for the selective valorization of biorefinery carbohydrates
are known, processes of similar selectivity for the valorization of
lignin are scarce, which can be attributed to its heterogeneity arising
from its biosynthesis, as well as methods used for its isolation within
the biorefinery. This perspective highlights advances within the last
six years toward lignin valorization in the areas of thermochemical
transformations, oxidations, reductions, and the tailoring of the
lignin biosynthetic pathway in an effort to produce high-value chemicals
and fuels. Should these current hurdles be addressed, significant
progress can be made toward the realization of biomass replacing petroleum
in meeting the world’s energy and chemical needs.
We describe an efficient five-step, enantioselective synthesis of (R,R)- and (S,S)-lignin dimer models possessing a β-O-4 linkage, by using the Evans chiral aldol reaction as a key step. Mitsunobu inversion of the (R,R)- or (S,S)-isomers generates the corresponding (R,S)- and (S,R)-diastereomers. We further extend this approach to the enantioselective synthesis of a lignin trimer model. These lignin models are synthesized with excellent ee (>99 %) and high overall yields. The lignin dimer models can be scaled up to provide multigram quantities that are not attainable by using previous methodologies. These lignin models will be useful in degradation studies probing the selectivity of enzymatic, microbial, and chemical processes that deconstruct lignin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.